Showing results (231-240 of 352) with videos related to
Sort By:
Pageof 36
Journal of Medical Economics|February 23, 2024
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancerChristine M Bestvina, Dexter Waters, Laura Morrison, et al.The Journal of Clinical Psychiatry|April 7, 2022
Economic Burden of Commercially Insured Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior in the United StatesDominic Pilon, Cheryl Neslusan, Maryia Zhdanava, et al.Current Medical Research and Opinion|November 23, 2017
Implications of stroke and bleeding risk scores and comorbidities on episode-based bundled payments for patients with nonvalvular atrial fibrillationScott Kaatz, Craig I Coleman, Brahim Bookhart, et al.Current Medical Research and Opinion|June 10, 2009
Projected economic impact of clinical findings of generic entry of topiramate on G4 European countriesPierre Emmanuel Paradis, Dominick Latrémouille-Viau, Yuliya Moore, et al.Current Medical Research and Opinion|December 12, 2018
The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophreniaAntoine C El Khoury, Dominic Pilon, Laura Morrison, et al.Frontiers in Psychiatry|June 3, 2021
Effects of Hormonal Contraception Use on Cognitive Functions in Patients With Bulimia NervosaBenedicte Nobile, Laurent Maimoun, Isabelle Danielle Jaussent, et al.Urologic Oncology|April 15, 2023
Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamideBenjamin Lowentritt, Dominic Pilon, Ibrahim Khilfeh, et al.The Oncologist|July 31, 2024
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancerMehmet A Bilen, Ibrahim Khilfeh, Carmine Rossi, et al.Allergy and Asthma Proceedings|February 21, 2018
Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United StatesJacqueline Eghrari-Sabet, Ellen Sher, Abhishek Kavati, et al.Dermatology and Therapy|February 12, 2018
Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United StatesPaul V Williams, Abhishek Kavati, Dominic Pilon, et al.Pageof 36